Category: Press Release

Explore all our news . .

Recent Posts

Insilico Medicine Appoints Michael Bayewitch as VP, Business Development and Strategy

Abu Dhabi, May 15, 2023 (GLOBE NEWSWIRE) — Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has appointed Michael Bayewitch, PhD, as Vice President (VP) of Business Development and Strategy. Based on the U.S. West Coast, Dr. Bayewitch will work closely with Alex Zhavoronkov, PhD, founder and

Insilico Medicine Appoints Michael Bayewitch as VP, Business Development and Strategy

Abu Dhabi, May 15, 2023 (GLOBE NEWSWIRE) — Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has appointed Michael Bayewitch, PhD, as Vice President (VP) of Business Development and Strategy. Based on the U.S. West Coast, Dr. Bayewitch will work closely with Alex Zhavoronkov, PhD, founder and

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages BurgerFi International, Inc. f/k/a Opes Acquisition Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BFI, OPES

NEW YORK, May 14, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BurgerFi International, Inc. f/k/a Opes Acquisition Corp. (NASDAQ: BFI, OPES) between December 17, 2020 and November 15, 2022, both dates inclusive (the “Class Period”), of the important

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages BurgerFi International, Inc. f/k/a Opes Acquisition Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BFI, OPES

NEW YORK, May 14, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BurgerFi International, Inc. f/k/a Opes Acquisition Corp. (NASDAQ: BFI, OPES) between December 17, 2020 and November 15, 2022, both dates inclusive (the “Class Period”), of the important